Replies to post #249540 on Biotech Values

[mouton29]

Re: ENTA

a deal would have to be made before the winter when Covid is expected to spike.

Why? Do you think current levels don’t generate enough cases to enroll a moderate sized noninferiority trial? 250,000 courses of Paxlovid are being administered weekly. https://www.reuters.com/business/healthcare-pharmaceuticals/about-250000-courses-covid-pill-paxlovid-being-administered-per-week-pfizer-ceo-2023-09-26/